Loading…
Loading…
NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2026, has a record date of September 15, 2026, and has an ex-date of September 15, 2026.
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") announced today that its Board of Directors has approved a $25 million increase in the committed debt financing available under its revolving debt financing facility ("Revolving Loan Facility") with a major unaffiliated financial institution, as well as the issuance of $10 million in additional Mandatory Redeemable Preferred Shares, Series D ("Series D Preferred Shares"), in each case subject to completion of documentation and customary closing conditions. The Fund anticipates finalizing the amendment to Revolving Loan Facility and issuing the Series D Preferred Shares within the next week.
NEW YORK, July 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on August 31, 2026, has a record date of August 17, 2026, and has an ex-date of August 17, 2026.
Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $6.79 and traded as low as $6.11. Neuberger Berman High Yield Strategies Fund shares last traded at $6.12, with a volume of 68,514 shares.
Ventripoint's VMS+ platform to be evaluated alongside a second AI technology in a landmark NHS study exploring earlier detection of chemotherapy-related heart damage Toronto, Ontario – TheNewswire – July 20, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a leader in the application of artificial intelligence to echocardiography, today announced that its VMS+ technology has been selected for use in AIRES (Artificial Intelligence Reconstruction of Echocardiography Study), a newly launched clinical research study at The Royal Wolverhampton NHS Trust (RWT) in the United Kingdom.
As small-business owners face rising operating costs, ComEd is marking a major milestone: more than 100,000 small businesses across northern Illinois have compl
Neuberger High Yield Strategies Fund is downgraded to a sell due to persistent NAV erosion and unsustainable distributions. NHS trades at a 6.6% discount to NAV and offers a 17.4% yield, but earnings consistently fail to cover payouts, risking further capital deterioration. Leverage at 26.7% and 98% below-investment-grade exposure amplifies risks in a rising rate and higher default environment.
NEW YORK, June 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on July 31, 2026, has a record date of July 15, 2026, and has an ex-date of July 15, 2026.